Search results
Author(s):
Renzo Laborante
,
Attilio Restivo
,
Daniela Mele
,
et al
Added:
1 week ago
Author(s):
Silvana Di Maio
,
Ritu Thamman
,
Julia Grapsa
Added:
6 months ago
Background of Heart Failure
Author(s):
Raluca Ibănescu
,
Diana-Alexandra Mîțu
,
Iacob-Daniel Goje
,
et al
Added:
1 month ago
Article
Author(s):
Shrilla Banerjee
,
Mirvat Alasnag
,
Marta Kałuzna-Oleksy
,
et al
Added:
5 months ago
In this video, Dr Marta Kałużna-Oleksy is joined by Dr Mirvat Alasnag, Dr Shrilla Banerjee and Dr Michal Hawranek to discuss strategies for heart failure management, based on a presentation at the Prevention and Intervention meeting in 2024.The faculty discuss SCAD, MINOCA and holistic approaches to managing these conditions, including lifestyle factors, hypertension and diabetes. They outline…
View more
Global Heart Failure Burden
Author(s):
Bahira Shahim
,
Chris J Kapelios
,
Gianluigi Savarese
,
et al
Added:
1 year ago
Article
Heart Failure in South Asians
Author(s):
Nikhilesh Srinivasan
,
Nagesh Gullapalli
,
Kevin S Shah
Added:
10 months ago
Article
The Burden of Disease of HFpEF
Author(s):
Chris J Kapelios
,
Bahira Shahim
,
Lars H Lund
,
et al
Added:
1 year ago
Article
Author(s):
Diana Hui Ping Foo
Added:
2 days ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,…
View more
Author(s):
Ritu Thamman
,
Naeimeh Hosseini
,
Marie-Luise Dikou
,
et al
Added:
8 months ago
Author(s):
Marianna Fontana
Added:
3 days ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,…
View more